Director buying at Isodiol International (ISOL)

Director buying at Isodiol International (C:ISOL)

Updated Thursday Apr 04, 2019 02:35 AM EDT
Leonardo Matesanz, a Director, acquired 250,000 Common Shares on a direct ownership basis at a price of $1.350 through a prospectus or prospectus exempt offering on March 29th, 2019. This represents a $337,500 investment into the company's shares and an account share holdings change of 62.5%.

Isodiol International is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Isodiol International Inc, formerly Laguna Blends Inc, is a Canada-based company specializing in the development of pharmaceutical and consumer products. The Company is focused on the nutritional health benefits that are derived from hemp and is a product development, sales, marketing and distribution company of hemp-based consumer products and solutions. Its nutraceutical division is focused on hemp-derived products, including crystalline isolate, micro-encapsulation, and nanotechnology for the consumable and topical skin care products. It is also focused on over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries.


Top